undamentalytics Newsletter
Sign in

Infusystem Holdings, Inc income statement

In fiscal 2025, Infusystem Holdings, Inc reported revenue of $143m, up 6.4% on the year before, operating income of $11.9m (a 8.3% margin) and net income of $6.6m, or $0.31 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue394755596266717071678197102110126135143143
Cost of revenue68991112141618283439444963646361
Gross profit293435434447504543404759596163708082
Selling and marketing57910101010101091010111213111011
General and administrative122118231920242525252935414445515757
Operating income5−1−6626971−404932471213
Interest expense332333211121112211
Income before tax2−3−69−2364−0−5−12810251112
Income tax1−1−23−1131−01500−10−001344
Net income1−2−45−1233−0−21−1117101279
Diluted EPS$0.04−$0.09−$2.16−$0.07$0.08$0.15$0.12−$0.01−$0.91−$0.05$0.07$0.80$0.06$0.00$0.04$0.11$0.31$0.41
Diluted shares (average)19m20m21m21m22m23m23m23m23m21m21m22m22m22m22m22m21m21m
EBITDA94−60811131383121623171517192526

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INFU vs STIMINFU vs RXSTBBNX vs INFU

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Infusystem Holdings, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Infusystem Holdings, Inc.